NCT04551339

Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19

Zinc Versus Multivitamin Micronutrient Supplementation to Support Immune Health in the Setting of COVID-19 Pandemic: A Randomized Study

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 2,700 (actual)
• Sponsor: Mayo Clinic · Academic / Other
• Sex: All
• Age: 18 Years – 90 Years
• Healthy volunteers: Accepted

Summary

The purpose of this research study is to look at high dose zinc versus multivitamin micronutrient supplementation to support immune health in the setting of the COVID-19 pandemic.

Detailed description

This is a two-cohort prospective randomized study intended to test the role of Zinc versus multivitamin supplementation in supporting immune health in the setting of the COVID-19 pandemic. Individuals over 50 years old or primary health care professionals over the age of 18 who have had no evidence of prior COVID-19 infection and who have been asymptomatic for 7 days prior to enrollment will be randomized at the individual level to take either PreserVision AREDS formulation soft gels or tablets with 69.6mg/day Zinc supplementation or to receive a multivitamin supplement with 11mg of zinc/day.

Conditions

• Healthy
• Health Care Worker Patient Transmission
• Aging

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	PreserVision AREDS formulation soft gels or tablets	Two tabs taken daily for three months
DIETARY_SUPPLEMENT	Multivitamin with 11mg of zinc	One tab taken daily for three months

Timeline

• Start date: 2020-09-28
• Primary completion: 2021-05-28
• Completion: 2021-05-28
• First posted: 2020-09-16
• Last updated: 2021-08-10

Locations

3 sites across 1 country: United States